West Pharmaceutical Services, Inc. (LON:0ADY)
London flag London · Delayed Price · Currency is GBP · Price in USD
238.10
-18.08 (-7.06%)
At close: Jan 28, 2026

LON:0ADY Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,0742,8932,9502,8872,832
Revenue Growth (YoY)
6.25%-1.92%2.18%1.95%31.89%
Cost of Revenue
1,9701,8951,8201,7511,654
Gross Profit
1,104998.51,1301,1361,178
Selling, General & Admin
388.7334.9354.1316356.3
Research & Development
74.369.168.458.552.8
Other Operating Expenses
28.30.91.3-2.1-
Operating Expenses
491.3404.9423.8372.4409.1
Operating Income
612.7593.6706.2763.8768.6
Interest Expense
--3-9-7.9-8.2
Interest & Investment Income
1719.6285.11
Earnings From Equity Investments
14.414.717.720.720.1
Currency Exchange Gain (Loss)
--10.2-9.44.11.4
Other Non Operating Income (Expenses)
-1----
EBT Excluding Unusual Items
643.1614.7733.5785.8782.9
Merger & Restructuring Charges
-23.3-2.12-23.8-2.2
Gain (Loss) on Sale of Investments
-4.5-0.3-4.3-3.5-4.3
Gain (Loss) on Sale of Assets
---11.6--
Asset Writedown
--7-5.3-2.7-4.1
Legal Settlements
--3.8--
Other Unusual Items
--5.1-2.4-55.2-3.3
Pretax Income
615.3600.2715.7700.6769
Income Tax Expense
121.6107.5122.3114.7107.2
Net Income
493.7492.7593.4585.9661.8
Net Income to Common
493.7492.7593.4585.9661.8
Net Income Growth
0.20%-16.97%1.28%-11.47%91.16%
Shares Outstanding (Basic)
7273747474
Shares Outstanding (Diluted)
7374757676
Shares Change (YoY)
-1.36%-2.13%-0.66%-0.66%0.66%
EPS (Basic)
6.836.757.997.888.90
EPS (Diluted)
6.796.697.887.738.67
EPS Growth
1.49%-15.10%1.94%-10.84%89.72%
Free Cash Flow
468.9276.4414.5439.4330.6
Free Cash Flow Per Share
6.453.755.505.804.33
Dividend Per Share
0.8500.8100.7700.7300.690
Dividend Growth
4.94%5.20%5.48%5.80%6.15%
Gross Margin
35.91%34.51%38.31%39.36%41.59%
Operating Margin
19.93%20.52%23.94%26.46%27.14%
Profit Margin
16.06%17.03%20.12%20.29%23.37%
Free Cash Flow Margin
15.25%9.55%14.05%15.22%11.68%
EBITDA
784.1749843.5884.4890.9
EBITDA Margin
25.51%25.89%28.59%30.64%31.46%
D&A For EBITDA
171.4155.4137.3120.6122.3
EBIT
612.7593.6706.2763.8768.6
EBIT Margin
19.93%20.52%23.94%26.46%27.14%
Effective Tax Rate
19.76%17.91%17.09%16.37%13.94%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.